Related references
Note: Only part of the references are listed.Dual-Tracer (68Ga-DOTATOC and 18F-FDG-)-PET/CT Scan and G1-G2 Nonfunctioning Pancreatic Neuroendocrine Tumors: A Single-Center Retrospective Evaluation of 124 Nonmetastatic Resected Cases
Salvatore Paiella et al.
NEUROENDOCRINOLOGY (2022)
Pancreatic Neuroendocrine Tumors in Patients with Multiple Endocrine Neoplasia Type 1: Diagnostic Value of Different MRI Sequences
Francesco Verde et al.
NEUROENDOCRINOLOGY (2021)
Reliability and Agreement of Radiological and Pathological Tumor Size in Patients with Multiple Endocrine Neoplasia Type 1-Related Pancreatic Neuroendocrine Tumors: Results from a Population-Based Cohort
Dirk-Jan van Beek et al.
NEUROENDOCRINOLOGY (2021)
Theranostics in neuroendocrine tumors: an overview of current approaches and future challenges
Julie Refardt et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2021)
Advances in the Diagnosis and Management of Well-Differentiated Neuroendocrine Neoplasms
Johannes Hofland et al.
ENDOCRINE REVIEWS (2020)
The 2019 WHO classification of tumours of the digestive system
Iris D. Nagtegaal et al.
HISTOPATHOLOGY (2020)
Cholecystokinin 2 Receptor Agonist 177Lu-PP-F11N for Radionuclide Therapy of Medullary Thyroid Carcinoma: Results of the Lumed Phase 0a Study
Christof Rottenburger et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
64Cu-DOTATATE PET/CT for Imaging Patients with Known or Suspected Somatostatin Receptor-Positive Neuroendocrine Tumors: Results of the First US Prospective, Reader-Masked Clinical Trial
Ebrahim S. Delpassand et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Treatment-related changes in neuroendocrine tumors as assessed by textural features derived from 68Ga-DOTATOC PET/MRI with simultaneous acquisition of apparent diffusion coefficient
Manuel Weber et al.
BMC CANCER (2020)
Commonwealth Neuroendocrine Tumour Research Collaboration and the North American Neuroendocrine Tumor Society Guidelines for the Diagnosis and Management of Patients With Lung Neuroendocrine Tumors: An International Collaborative Endorsement and Update of the 2015 European Neuroendocrine Tumor Society Expert Consensus Guidelines
Simron Singh et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Pancreatic Neuroendocrine Tumors
Thorvardur R. Halfdanarson et al.
PANCREAS (2020)
Pitfalls in the Detection of Insulinomas With Glucagon-Like Peptide-1 Receptor Imaging
Kwadwo Antwi et al.
CLINICAL NUCLEAR MEDICINE (2020)
68Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers
Frederik L. Giesel et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer
Clemens Kratochwil et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma
David Taieb et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
CT radiomics may predict the grade of pancreatic neuroendocrine tumors: a multicenter study
Dongsheng Gu et al.
EUROPEAN RADIOLOGY (2019)
A Combined Nomogram Model to Preoperatively Predict Histologic Grade in Pancreatic Neuroendocrine Tumors
Wenjie Liang et al.
CLINICAL CANCER RESEARCH (2019)
Efficacy and Safety of High-Specific-Activity 131I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma
Daniel A. Pryma et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Small intestinal neuroendocrine tumours and fibrosis: an entangled conundrum
Anela Blazevic et al.
ENDOCRINE-RELATED CANCER (2018)
Safety, Biodistribution, and Radiation Dosimetry of 68Ga-OPS202 in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase I Imaging Study
Guillaume P. Nicolas et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Sensitivity Comparison of 68Ga-OPS202 and 68Ga-DOTATOC PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase II Imaging Study
Guillaume P. Nicolas et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Clinical Usefulness of F-18-Fluorodeoxyglucose Positron Emission Tomography in the Diagnostic Algorithm of Advanced Entero-Pancreatic Neuroendocrine Neoplasms
Maria Rinzivillo et al.
ONCOLOGIST (2018)
Clinical and Prognostic Value of PET/CT Imaging with Combination of Ga-68-DOTATATE and F-18-FDG in Gastroenteropancreatic Neuroendocrine Neoplasms
Panpan Zhang et al.
CONTRAST MEDIA & MOLECULAR IMAGING (2018)
[18F]DOPA PET/ceCT in diagnosis and staging of primary medullary thyroid carcinoma prior to surgery
Sazan Rasul et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Comparison of glucagon-like peptide-1 receptor (GLP-1R) PET/CT, SPECT/CT and 3T MRI for the localisation of occult insulinomas: evaluation of diagnostic accuracy in a prospective crossover imaging study
Kwadwo Antwi et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
The differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma: the values of CT imaging features and texture analysis
Chuangen Guo et al.
CANCER IMAGING (2018)
Current Consensus on I-131 MIBG Therapy
Daiki Kayano et al.
NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Predictive and prognostic value of 18F-DOPA PET/CT in patients affected by recurrent medullary carcinoma of the thyroid
Federico Caobelli et al.
ANNALS OF NUCLEAR MEDICINE (2018)
Localization of Insulinoma Using 68Ga-DOTATATE PET/CT Scan
Pavel Nockel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Head-to-Head Comparison of 64Cu-DOTATATE and 68Ga-DOTATOC PET/CT: A Prospective Study of 59 Patients with Neuroendocrine Tumors
Camilla B. Johnbeck et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Effect of hormone secretory syndromes on neuroendocrine tumor prognosis
Wouter T. Zandee et al.
ENDOCRINE-RELATED CANCER (2017)
Somatostatin analogues labeled with copper radioisotopes: current status
Aleksandra Marciniak et al.
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY (2017)
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging
Anders Sundin et al.
NEUROENDOCRINOLOGY (2017)
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pathology-Diagnosis and Prognostic Stratification
Aurel Perren et al.
NEUROENDOCRINOLOGY (2017)
Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance
David L. H. Chan et al.
THERANOSTICS (2017)
Imaging of Chemokine Receptor 4 Expression in Neuroendocrine Tumors - a Triple Tracer Comparative Approach
Rudolf A. Werner et al.
THERANOSTICS (2017)
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
Arvind Dasari et al.
JAMA ONCOLOGY (2017)
Comparison of the 68Ga-DOTATATA PET/CT, FDG PET/CT, and MIBG SPECT/CT in the Evaluation of Suspected Primary Pheochromocytomas and Paragangliomas
Hongli Jing et al.
CLINICAL NUCLEAR MEDICINE (2017)
Compared to 123I-MIBG SPECT/CT, 18F-DOPA PET/CT provides accurate tumor extent in patients with extra-adrenal paraganglioma
Alexander Stephan Kroiss et al.
ANNALS OF NUCLEAR MEDICINE (2017)
Perfusion CT Changes in Liver Metastases from Pancreatic Neuroendocrine Tumors During Everolimus Treatment
Mirko D'Onofrio et al.
ANTICANCER RESEARCH (2017)
Comparison of diagnostic accuracy of 111In-pentetreotide SPECT and 68Ga-DOTATOC PET/CT: A lesion-by-lesion analysis in patients with metastatic neuroendocrine tumours
S. Van Binnebeek et al.
EUROPEAN RADIOLOGY (2016)
Medullary thyroid carcinoma - PET/CT imaging with 68Ga-labelled gastrin and somatostatin analogues
Jolanta Kunikowska et al.
ENDOKRYNOLOGIA POLSKA (2016)
Pancreatic neuroendocrine tumour: Correlation of apparent diffusion coefficient or WHO classification with recurrence-free survival
Mimi Kim et al.
EUROPEAN JOURNAL OF RADIOLOGY (2016)
Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites
Samira M. Sadowski et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors
Stephen A. Deppen et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Preoperative Identification of a Prognostic Factor for Pancreatic Neuroendocrine Tumors Using Multiphase Contrast-Enhanced Computed Tomography
Suguru Yamada et al.
PANCREAS (2016)
Diagnosis of Small-Bowel Diseases: Prospective Comparison of Multi-Detector Row CT Enterography with MR Enterography
Gabriele Masselli et al.
RADIOLOGY (2016)
[68Ga]Pentixafor-PET/CT for imaging of chemokine receptor 4 expression in small cell lung cancer - initial experience
Constantin Lapa et al.
ONCOTARGET (2016)
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids
M. E. Caplin et al.
ANNALS OF ONCOLOGY (2015)
64Cu-DOTATATE PET for Neuroendocrine Tumors: A Prospective Head-to-Head Comparison with 111In-DTPA-Octreotide in 112 Patients
Andreas Pfeifer et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Localization of Hidden Insulinomas with 68Ga-DOTA-Exendin-4 PET/CT: A Pilot Study
Kwadwo Antwi et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Incremental Value of Liver MR Imaging in Patients with Potentially Curable Colorectal Hepatic Metastasis Detected at CT: A Prospective Comparison of Diffusion-weighted Imaging, Gadoxetic Acid-enhanced MR Imaging, and a Combination of Both MR Techniques
Hye Jin Kim et al.
RADIOLOGY (2015)
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
Samuel A. Wells et al.
THYROID (2015)
Differential expression and prognostic value of the chemokine receptor CXCR4 in bronchopulmonary neuroendocrine neoplasms
Daniel Kaemmerer et al.
ONCOTARGET (2015)
Inverse expression of somatostatin and CXCR4 chemokine receptors in gastroenteropancreatic neuroendocrine neoplasms of different malignancy
Daniel Kaemmerer et al.
ONCOTARGET (2015)
Contrast enhancement pattern on multidetector CT predicts malignancy in pancreatic endocrine tumours
Carla Cappelli et al.
EUROPEAN RADIOLOGY (2015)
Diagnostic Performance of 68Ga-DOTATATE PET/CT, 18F-FDG PET/CT and 131I-MIBG Scintigraphy in Mapping Metastatic Pheochromocytoma and Paraganglioma
Teik Hin Tan et al.
NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Diagnostic role of Gallium-68 DOTATOC and Gallium-68 DOTATATE PET in patients with neuroendocrine tumors: a meta-analysis
Jigang Yang et al.
ACTA RADIOLOGICA (2014)
PET tracers for somatostatin receptor imaging of neuroendocrine tumors: current status and review of the literature
Camilla Bardram Johnbeck et al.
FUTURE ONCOLOGY (2014)
Quantitative and Qualitative Intrapatient Comparison of 68Ga-DOTATOC and 68Ga-DOTATATE: Net Uptake Rate for Accurate Quantification
Irina Velikyan et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
The Glucose-Dependent Insulinotropic Polypeptide Receptor: A Novel Target for Neuroendocrine Tumor Imaging-First Preclinical Studies
Eleni Gourni et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
High Prognostic Value of 18F-FDG PET for Metastatic Gastroenteropancreatic Neuro endocrine Tumors: A Long-Term Evaluation
Haifa Bahri et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
PET and PET/CT with 68Gallium-Labeled Somatostatin Analogues in Non GEP-NETs Tumors
Martina Sollini et al.
SCIENTIFIC WORLD JOURNAL (2014)
18F-Fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type
Sona Balogova et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Long-Term Outcome and Toxicity After Dose-Intensified Treatment with 131I-MIBG for Advanced Metastatic Carcinoid Tumors
Samer Ezziddin et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT Within Patients with Gastroenteropancreatic Neuroendocrine Tumors
Damian Wild et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study
Emanuel Christ et al.
LANCET DIABETES & ENDOCRINOLOGY (2013)
Clinical PET of Neuroendocrine Tumors Using 64Cu-DOTATATE: First-in-Humans Study
Andreas Pfeifer et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Unexpected Sensitivity of sst2 Antagonists to N-Terminal Radiometal Modifications
Melpomeni Fani et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta-analysis
Giorgio Treglia et al.
ENDOCRINE (2012)
68Ga-DOTATOC Versus 68Ga-DOTATATE PET/CT in Functional Imaging of Neuroendocrine Tumors
Thorsten D. Poeppel et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Glucagon-Like Peptide-1 Versus Somatostatin Receptor Targeting Reveals 2 Distinct Forms of Malignant Insulinomas
Damian Wild et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Evaluation of 177Lu-DOTA-sst2 Antagonist Versus 177Lu-DOTA-sst2 Agonist Binding in Human Cancers In Vitro
Renzo Cescato et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Incremental Value of 111-In Pentetreotide SPECT/CT Fusion Imaging of Neuroendocrine Tumors
Ka Kit Wong et al.
ACADEMIC RADIOLOGY (2010)
Value of CT Enteroclysis in Suspected Small-Bowel Carcinoid Tumors
Imane Kamaoui et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2010)
18F-Fluorodeoxyglucose Positron Emission Tomography Predicts Survival of Patients with Neuroendocrine Tumors
Tina Binderup et al.
CLINICAL CANCER RESEARCH (2010)
MR Enteroclysis in the Diagnosis of Small-Bowel Neoplasms
Stijn J. B. Van Weyenberg et al.
RADIOLOGY (2010)
Glucagon-Like Peptide-1 Receptor Imaging for Localization of Insulinomas
Emanuel Christ et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Predictive Value of 18F-FDG PET and Somatostatin Receptor Scintigraphy in Patients with Metastatic Endocrine Tumors
Etienne Garin et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Somatostatin Receptor Imaging with In-111-Pentetreotide
Dik J. Kwekkeboom et al.
NEUROENDOCRINOLOGY (2009)
Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours
Valentina Ambrosini et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Glucagon-like peptide 1-receptor scans to localize occult insulinomas
Damian Wild et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Fluorine-18 DOPA-PET and PET/CT Imaging in Congenital Hyperinsulinism
Mohamed Houseni et al.
PET CLINICS (2008)
Biology of incretins: GLP-1 and GIP
Laurie L. Baggio et al.
GASTROENTEROLOGY (2007)
68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors:: Comparison with somatostatin receptor scintigraphy and CT
Michael Gabriel et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors
Mihaela Ginj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Detection of liver metastases from endocrine tumors: A prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging
C Dromain et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Peptide receptors as molecular targets for cancer diagnosis and therapy
JC Reubi
ENDOCRINE REVIEWS (2003)
Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting
JC Reubi et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)
MR imaging of hepatic metastases caused by neuroendocrine tumors: Comparing four techniques
C Dromain et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2003)
Detection of small, functional islet cell tumors in the pancreas: Selection of MR imaging sequences for optimal sensitivity
RF Thoeni et al.
RADIOLOGY (2000)
Share Paper
